Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer

Disease Markers

Volumn 23, Issue 1-2, 2007, Pages 105-112

  Cui, Hengmi ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Cancer; IGF2; Loss of imprinting

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; DEOXYRIBONUCLEASE; GENOMIC DNA; RNA; SOMATOMEDIN B;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT DISEASE; ALLELE; ARTICLE; BLADDER CARCINOMA; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CHILDHOOD CANCER; CHORIOCARCINOMA; CHRONIC MYELOID LEUKEMIA; COLON CANCER; COLON CARCINOGENESIS; COLORECTAL CANCER; DIAGNOSTIC APPROACH ROUTE; EPIGENETICS; ESOPHAGUS CANCER; EXON; FEMALE GENITAL TRACT TUMOR; GENE DISRUPTION; GENE DOSAGE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC MARKER; GENOME IMPRINTING; GLIOMA; HEAD AND NECK CARCINOMA; HEMATOLOGIC MALIGNANCY; HEPATOBLASTOMA; HUMAN; IN SITU HYBRIDIZATION; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LUNG CANCER; NASOPHARYNX FIBROMA; NEPHROBLASTOMA; NONHUMAN; OSTEOSARCOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; RIBONUCLEASE PROTECTION ASSAY; RISK ASSESSMENT; STEM CELL; STOMACH ADENOCARCINOMA; TESTIS TUMOR; TROPHOBLASTIC TUMOR; UTERINE CERVIX CARCINOMA; UTERUS MYOMA;

EID: 33847358273     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/363464     Document Type: Article

References (74)

1. G.I. Adam, H. Cui, S.J. Miller, F. Flam and R. Ohlsson, Allelespecific in situ hybridization (ASISH) analysis: a novel technique which resolves differential allelic usage of H19 within the same cell lineage during human placental development, Development 122 (1996), 839-847.
2. T. Arima, T. Matsuda, N. Takagi and N. Wake, Association of IGF2 and H19 imprinting with choriocarcinoma development, Cancer Genet Cytogenet 93 (1997), 39-47.
3. N.E. Breslow and J.B. Beckwith, Epidemiological features of Wilms' tumor: results of the National Wilms' Tumor Study, J Natl Cancer Inst 68 (1982), 429-436.
4. N.E. Breslow, P.A. Norkool, A. Olshan, A. Evans and G.J. D'Angio, Second malignant neoplasms in survivors of Wilms' tumor: a report from the National Wilms' Tumor Study, J Natl Cancer Inst 80 (1988), 592-595.
5. C.L. Chen, S.M. Ip, D. Cheng, L.C. Wong and H.Y. Ngan, Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer, Clin Cancer Res 6 (2000), 474-479.
6. C.M. Coutinho-Camillo, M.M. Brentani, O. Butugan, H. Torloni and M.A. Nagai, Relaxation of imprinting of IGFII gene in juvenile nasopharyngeal angiofibromas, Diagn Mol Pathol 12 (2003), 57-62.
7. H. Cui, I.L. Horon, R. Ohlsson, S.R. Hamilton and A.P. Feinberg, Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability, Nat Med 4 (1998), 1276-1280.
8. H. Cui, E.L. Niemitz, J.D. Ravenel, P. Onyango, S.A. Brandenburg, V.V. Lobanenkov and A.P. Feinberg, Loss of imprinting of insulin-like growth factor-II inWilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site, Cancer Res 61 (2001), 4947-4950.
9. H. Cui and R. Ohlsson, An improved protocol for purification of 35S-labelled oligonucleotide DNA probes for in situ hybridization applications, Trends Genet 12 (1996), 506-507.
10. H. Cui, P. Onyango, S. Brandenburg, Y. Wu, C.L. Hsieh and A.P. Feinberg, Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2, Cancer Res 62 (2002), 6442-6446.
11. S.M. Davies, Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma, Cancer Res 53 (1993), 4781-4783.
12. T.M. DeChiara, E.J. Robertson and A. Efstratiadis, Parental imprinting of the mouse insulin-like growth factor II gene, Cell 64 (1991), 849-859.
13. S. Douc-Rasy, M. Barrois, S. Fogel, J.C. Ahomadegbe, D. Stehelin, J. Coll and G. Riou, High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19, Oncogene 12 (1996), 423-430.
14. T.J. Ekstrom, H. Cui, X. Li and R. Ohlsson, Promoter-specific IGF2 imprinting status and its plasticity during human liver development, Development 121 (1995), 309-316.
15. M. Elkin, A. Shevelev, E. Schulze, M. Tykocinsky, M. Cooper, I. Ariel, D. Pode, E. Kopf, N. de Groot and A. Hochberg, The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma, FEBS Lett 374 (1995), 57-61.
16. A.K. el-Naggar, S. Lai, S.A. Tucker, G.L. Clayman, H. Goepfert, W.K. Hong and V. Huff, Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma, Oncogene 18 (1999), 7063-7069.
17. H. Fakhrai-Rad, N. Pourmand and M. Ronaghi, Pyrosequencing: an accurate detection platform for single nucleotide polymorphisms, Hum Mutat 19 (2002), 479-485.
18. A.P. Feinberg, R. Ohlsson and S. Henikoff, The epigenetic progenitor origin of human cancer, Nat Rev Genet 7 (2006), 21-33.
19. R. Fukuzawa, A. Umezawa, K. Ochi, F. Urano, H. Ikeda and J. Hata, High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma, Int J Cancer 82 (1999), 490-497.
20. C.F. Graham, The production of parthenogenetic mammalian embryos and their use in biological research, Biol Rev Camb Philos Soc 49 (1974), 399-424.
21. D.F. Jarrard, M.J. Bussemakers, G.S. Bova and W.B. Isaacs, Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues, Clin Cancer Res 1 (1995), 1471-1478.
22. H.T. Kim, B.H. Choi, N. Niikawa, T.S. Lee and S.I. Chang, Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors, Am J Med Genet 80 (1998), 391-395.
23. K.S. Kim and Y.I. Lee, Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma, Cancer Lett 119 (1997), 143-148.
24. S.J. Kim, S.E. Park, C. Lee, S.Y. Lee, I.H. Kim, H.J. An and Y.K. Oh, Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases, Gynecol Oncol 88 (2003), 411-418.
25. M. Kohda, H. Hoshiya, M. Katoh, I. Tanaka, R. Masuda, T. Takemura, M. Fujiwara and M. Oshimura, Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinoma, Mol Carcinog 31 (2001), 184-191.
26. M. Kondo and T. Takahashi, Altered genomic imprinting in the IGF2 and H19 genes in human lung cancer, Nippon Rinsho 54 (1996), 492-496.
27. X. Li, G. Adam, H. Cui, B. Sandstedt, R. Ohlsson and T.J. Ekstrom, Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting, Oncogene 11 (1995), 221-229.
28. X. Li, Z. Nong, C. Ekstrom, E. Larsson, H. Nordlinder, W.J. Hofmann, C. Trautwein, M. Odenthal, H.P. Dienes, T.J. Ekstrom and P. Schirmacher, Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma, Cancer Res 57 (1997), 2048-2054.
29. Y. Liu, B. Yang, H. Zhu and J. Wang, Loss of imprinting of insulin-like growth factor II gene in acute myeloid leukemia, Zhonghua Yi Xue Yi Chuan Xue Za Zhi 17 (2000), 39-41.
30. J. McGrath and D. Solter, Completion of mouse embryogenesis requires both the maternal and paternal genomes, Cell 37 (1984), 179-183.
31. A.E. Micha, S. Hahnel, H. Friess, M.W. Buchler, G. Adler and T.M. Gress, Genomic imprinting of IGF-II and H19 in adult human pancreatic tissues, Digestion 60 (1999), 477-483.
32. M. Montagna, C. Menin, L. Chieco-Bianchi and E. D'Andrea, Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma, J Cancer Res Clin Oncol 120 (1994), 732-736.
33. M. Mori, H. Inoue, T. Shiraishi, K. Mimori, K. Shibuta, H. Nakashima, K. Mafune, Y. Tanaka, H. Ueo, G.F. Barnard, K. Sugimachi and T. Akiyoshi, Relaxation of insulin-like growth factor 2 gene imprinting in esophageal cancer, Int J Cancer 68 (1996), 441-446.
34. T. Moulton, T. Crenshaw, Y. Hao, J. Moosikasuwan, N. Lin, F. Dembitzer, T. Hensle, L. Weiss, L. McMorrow, T. Loew et al., Epigenetic lesions at the H19 locus in Wilms' tumour patients, Nat Genet 7 (1994), 440-447.
35. S. Nishihara, T. Hayashida, K. Mitsuya, T.C. Schulz, M. Ikeguchi, N. Kaibara and M. Oshimura, Multipoint imprinting analysis in sporadic colorectal cancers with and without microsatellite instability, Int J Oncol 17 (2000), 317-322.
36. N. Nonomura, T. Miki, K. Nishimura, N. Kanno, Y. Kojima and A. Okuyama, Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors, J Urol 157 (1997), 1977-1979.
37. N. Nonomura, K. Nishimura, T. Miki, N. Kanno, Y. Kojima, M. Yokoyama and A. Okuyama, Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma, Cancer Res 57 (1997), 2575-2577.
38. H. Oda, H. Kume, Y. Shimizu, T. Inoue and T. Ishikawa, Loss of imprinting of igf2 in renal-cell carcinomas, Int J Cancer 75 (1998), 343-346.
39. O. Ogawa, M.R. Eccles, J. Szeto, L.A. McNoe, K. Yun, M.A. Maw, P.J. Smith and A.E. Reeve, Relaxation of insulin-like growth factor II gene imprinting implicated inWilms' tumour, Nature 362 (1993), 749-751.
40. R. Ohlsson, H. Cui, L. He, S. Pfeifer, H. Malmikumpu, S. Jiang, A.P. Feinberg and F. Hedborg, Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity, Cancer Res 59 (1999), 3889-3892.
41. R. Ohlsson, A. Nystrom, S. Pfeifer-Ohlsson, V. Tohonen, F. Hedborg, P. Schofield, F. Flam and T.J. Ekstrom, IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome, Nat Genet 4 (1993), 94-97.
42. R. Ohlsson, K. Svensson, H. Cui, H. Malmikumpu and G. Adam, Allele-Specific In SituHybridization (ASISH), Methods Mol Biol 181 (2001), 153-167.
43. C.A. Rainho, L.P.Kowalski and S.R. Rogatto, Loss of imprinting and loss of heterozygosity on 11p15.5 in head and neck squamous cell carcinomas, Head Neck 23 (2001), 851-859.
44. C.A. Rainho, A. Pontes and S.R. Rogatto, Expression and imprinting of insulin-like growth factor II (IGF2) and H19 genes in uterine leiomyomas, Gynecol Oncol 74 (1999), 375-380.
45. S. Rainier, C.J. Dobry and A.P. Feinberg, Loss of imprinting in hepatoblastoma, Cancer Res 55 (1995), 1836-1838.
46. S. Rainier, L.A. Johnson, C.J. Dobry, A.J. Ping, P.E. Grundy and A.P. Feinberg, Relaxation of imprinted genes in human cancer, Nature 362 (1993), 747-749.
47. G.S. Randhawa, H. Cui, J.A. Barletta, L.Z. Strichman-Almashanu, M. Talpaz, H. Kantarjian, A.B. Deisseroth, R.C. Champlin and A.P. Feinberg, Loss of imprinting in disease progression in chronic myelogenous leukemia, Blood 91 (1998), 3144-3147.
48. J.D. Ravenel, K.W. Broman, E.J. Perlman, E.L. Niemitz, T.M. Jayawardena, D.W. Bell, D.A. Haber, H. Uejima and A.P. Feinberg, Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor, J Natl Cancer Inst 93 (2001), 1698-1703.
49. I. Rhee, K.E. Bachman, B.H. Park, K.W. Jair, R.W. Yen, K.E. Schuebel, H. Cui, A.P. Feinberg, C. Lengauer, K.W. Kinzler, S.B. Baylin and B. Vogelstein, DNMT1 and DNMT3b cooperate to silence genes in human cancer cells, Nature 416 (2002), 552-556.
50. M. Ronaghi, Pyrosequencing sheds light on DNA sequencing, Genome Res 11 (2001), 3-11.
51. T. Sakatani, A. Kaneda, C.A. Iacobuzio-Donahue, M.G. Carter, S. de Boom Witzel, H. Okano, M.S. Ko, R. Ohlsson, D.L. Longo and A.P. Feinberg, Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice, Science 307 (2005), 1976-1978.
52. M.J. Steenman, S. Rainier, C.J. Dobry, P. Grundy, I.L. Horon and A.P. Feinberg, Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour, Nat Genet 7 (1994), 433-439.
53. L.C. Stevens, Totipotent cells of parthenogenetic origin in a chimaeric mouse, Nature 276 (1978), 266-267.
54. M.J. Sullivan, T. Taniguchi, A. Jhee, N. Kerr and A.E. Reeve, Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation, Oncogene 18 (1999), 7527-7534.
55. M.A. Surani, S.C. Barton and M.L. Norris, Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis, Nature 308 (1984), 548-550.
56. Y. Takano, G. Shiota and H. Kawasaki, Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer, Oncology 59 (2000), 210-216.
57. T. Taniguchi, M.J. Sullivan, O. Ogawa and A.E. Reeve, Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor, Proc Natl Acad Sci USA 92 (1995), 2159-2163.
58. H. Uejima, M.P. Lee, H. Cui and A.P. Feinberg, Hot-stop PCR: a simple and general assay for linear quantitation of allele ratios, Nat Genet 25 (2000), 375-376.
59. G.A. Ulaner, T.H. Vu, T. Li, J.F. Hu, X.M. Yao, Y. Yang, R. Gorlick, P. Meyers, J. Healey, M. Ladanyi and A.R. Hoffman, Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site, Hum Mol Genet 12 (2003), 535-549.
60. S. Uyeno, Y. Aoki, M. Nata, K. Sagisaka, T. Kayama, T. Yoshimoto and T. Ono, IGF2 but not H19 shows loss of imprinting in human glioma, Cancer Res 56 (1996), 5356-5359.
61. C.E. van Roozendaal, A.J. Gillis, J.G. Klijn, B. van Ooijen, C.J. Claassen, A.M. Eggermont, S.C. Henzen-Logmans, J.W. Oosterhuis, J.A. Foekens and L.H. Looijenga, Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures, FEBS Lett 437 (1998), 107-111.
62. P. Vorwerk, H. Wex, C. Bessert, B. Hohmann, U. Schmidt and U. Mittler, Loss of imprinting of IGF-II gene in children with acute lymphoblastic leukemia, Leuk Res 27 (2003), 807-812.
63. R.A. Waterland, J.R. Lin, C.A. Smith and R.L. Jirtle, Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus, Hum Mol Genet 15 (2006), 705-716.
64. R. Weksberg, D.R. Shen, Y.L. Fei, Q.L. Song and J. Squire, Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome, Nat Genet 5 (1993), 143-150.
65. K. Woodson, A. Flood, L. Green, J.A. Tangrea, J. Hanson, B. Cash, A. Schatzkin and P. Schoenfeld, Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women, J Natl Cancer Inst 96 (2004), 407-410.
66. H.K. Wu, R. Weksberg, M.D. Minden and J.A. Squire, Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia, Biochem Biophys Res Commun 231 (1997), 466-472.
67. M.S. Wu, H.P. Wang, C.C. Lin, J.C. Sheu, C.T. Shun, W.J. Lee and J.T. Lin, Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma, Cancer Lett 120 (1997), 9-14.
68. Y. Xiong, Y. Sun and H. Li, Different imprinting status of IGF-2 in epithelial ovarian tumors, J Huazhong Univ Sci Technolog Med Sci 22 (2002), 255-256.
69. G.L. Xu, T.H. Bestor, D. Bourc'his, C.L. Hsieh, N. Tommerup, M. Bugge, M. Hulten, X. Qu, J.J. Russo and E.Viegas-Pequignot, Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene, Nature 402 (1999), 187-191.
70. Y. Yaginuma, K. Nishiwaki, S. Kitamura, H. Hayashi, K. Sengoku and M. Ishikawa, Relaxation of insulin-like growth factor-II gene imprinting in human gynecologic tumors, Oncology 54 (1997), 502-507.
71. C.M. Yballe, T.H. Vu and A.R. Hoffman, Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor, J Clin Endocrinol Metab 81 (1996), 1607-1612.
72. K. Yun, M. Fukumoto and Y. Jinno, Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer, Am J Pathol 148 (1996), 1081-1087.
73. S. Zhan, D.N. Shapiro and L.J. Helman, Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma, J Clin Invest 94 (1994), 445-448.
74. F.R. Zhang, X.B. He, Y.H. Yang and W. Xie, The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer, Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20 (2003), 31-34.